Crossmark

Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [18F]F-FDG PET/CT in Patients with Liver Malignancies

Crossref DOI link: https://doi.org/10.1007/s11307-022-01732-2

Published Online: 2022-04-29

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Siripongsatian, Dheeratama https://orcid.org/0000-0001-7914-7141
Promteangtrong, Chetsadaporn

Kunawudhi, Anchisa

Kiatkittikul, Peerapon

Boonkawin, Natphimol

Chinnanthachai, Chatchawarin

Jantarato, Attapon

Chotipanich, Chanisa
License Information

Text and Data Mining valid from 2022-04-29

Version of Record valid from 2022-04-29
More Information

Article History

Received: 9 January 2022

Revised: 8 April 2022

Accepted: 14 April 2022

First Online: 29 April 2022

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below